Trials / Conditions / Central Nervous System Neoplasm

Central Nervous System Neoplasm

17 registered clinical trials studyying Central Nervous System Neoplasm — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiova NCT05169151	M.D. Anderson Cancer Center	—
Recruiting	Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors NCT07259304	University of Southern California	—
Recruiting	Cerebrospinal Fluid Biomarkers for Brain Tumors NCT04692324	Mayo Clinic	—
Completed	An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors NCT04539574	M.D. Anderson Cancer Center	N/A
Recruiting	Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology NCT04988009	M.D. Anderson Cancer Center	—
Active Not Recruiting	Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed A NCT03834961	Children's Oncology Group	Phase 2
Recruiting	Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System NCT03270059	OHSU Knight Cancer Institute	Phase 2
Completed	Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery NCT03071913	Mayo Clinic	—
Completed	Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types NCT03012620	UNICANCER	Phase 2
Active Not Recruiting	Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wi NCT02867592	National Cancer Institute (NCI)	Phase 2
Recruiting	Project: Every Child for Younger Patients With Cancer NCT02402244	Children's Oncology Group	—
Completed	High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors NCT01941758	Wake Forest University Health Sciences	Phase 1
Completed	Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous Sy NCT01538095	National Cancer Institute (NCI)	Phase 1
Completed	Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors NCT01474174	Wake Forest University Health Sciences	—
Completed	Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurren NCT01217437	National Cancer Institute (NCI)	Phase 2
Completed	Collecting and Storing Tissue From Young Patients With Cancer NCT00898755	Children's Oncology Group	—
Completed	Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas NCT00100802	Children's Oncology Group	Phase 2